“GLP-1 Receptor Agonists and Risk of Cardiac Arrhythmias: A Multi-Cohort Analysis of Atrial Fibrillation and Bradycardia in Diabetic Patients”, Pjmcr, vol. 5, no. 1, pp. 5997–6016, Mar. 2026, doi: 10.5281/zenodo.23696589.